Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 4, 2010, Pages 461-470

  Larose, Eric ^a   Tizon Marcos, Helena ^a   Rodés Cabau, Josep ^a   Rinfret, Stéphane ^a   Déry, Jean Pierre ^a   Nguyen, Can M ^a   Gleeton, Onil ^a   Boudreault, Jean Rock ^a   Roy, Louis ^a   Noël, Bernard ^a   Proulx, Guy ^a   Rouleau, Jacques ^a   Barbeau, Gérald ^a   De Larochellière, Robert ^a   Bertrand, Olivier F ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

angioplasty; coronary embolism; magnetic resonance imaging; myocardial infarction

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE NECROSIS; HUMAN; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE; PILOT STUDY; PROXIMAL EMBOLIC PROTECTION; Q WAVE; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARRHYTHMIAS, CARDIAC; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY THROMBOSIS; EMBOLIC PROTECTION DEVICES; EMBOLISM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PILOT PROJECTS; PROSPECTIVE STUDIES; QUEBEC; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 78649438156     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22588     Document Type: Article

References (38)

1. Keeley EC, Boura JA, Grines CL,. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
2. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM,. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111: 761-767.
3. Brodie BR, Stone GW, Cox DA, Stuckey TD, Turco M, Tcheng JE, Berger P, Mehran R, McLaughlin M, Costantini C, Lansky AJ, Grines CL,. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial. Am Heart J 2006; 151: 1231-1238.
4. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW,. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 51: 210-247.
5. Busk M, Kaltoft A, Nielsen SS, Bottcher M, Rehling M, Thuesen L, Botker HE, Lassen JF, Christiansen EH, Krusell LR, Andersen HR, Nielsen TT, Kristensen SD,. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J 2009; 30: 1322-1330.
6. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F,. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945.
7. Limbruno U, De Carlo M, Pistolesi S, Micheli A, Petronio AS, Camacci T, Fontanini G, Balbarini A, Mariani M, De Caterina R,. Distal embolization during primary angioplasty: Histopathologic features and predictability. Am Heart J 2005; 150: 102-108.
8. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van't Hof AW, Hoorntje JC, Suryapranata H,. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-1117.
9. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F,. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567.
10. Gorog DA,. The role of distal myocardial protection devices during percutaneous coronary interventions. Curr Treat Opt Cardiovasc Med 2007; 9: 52-59.
11. Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, Comberg T, Peitz K, Zohlnhofer D, Bassignana V, Buettner HJ, Neumann FJ,. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005; 112: 1462-1469.
12. Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Klovgaard L, Kaltoft A, Engstrom T, Botker HE, Saunamaki K, Krusell LR, Jorgensen E, Hansen HH, Christiansen EH, Ravkilde J, Kober L, Kofoed KF, Thuesen L,. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 2008; 51: 899-905.
13. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R,. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA 2005; 293: 1063-1072. (Pubitemid 40300280)
14. Quan VH, Huynh R, Seifert PA, Kuchela A, Chen WH, Sutsch G, Eisenhauer AC, Rogers C,. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Am J Cardiol 2005; 95: 1415-1419.
15. Haeck JD, Kuijt WJ, Koch KT, Bilodeau L, Henriques JP, Rohling WJ, Baan J Jr, Vis MM, Nijveldt R, Van Geloven N, Groenink M, Piek JJ, Tijssen JG, Krucoff MW, De Winter RJ,. Infarct size and left ventricular function in the Proximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: Ancillary cardiovascular magnetic resonance study. Heart 2010; 96: 190-195.
16. Koch KT, Haeck JD, Van Der Schaaf RJ, Alidjan FM, Henriques JP, Baan J Jr, Piek JJ, Van Der Wal AC, Tijssen JG, Sutsch G, De Winter RJ,. Proximal embolic protection with aspiration in percutaneous corononary intervention using the proxistrade mark device. Rev Cardiovasc Med 2007; 8: 160-166.
17. Larose E, Cote J, Rodes-Cabau J, Noel B, Barbeau G, Bordeleau E, Miro S, Brochu B, Delarochelliere R, Bertrand OF,. Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction. Int J Cardiovasc Imaging 2009; 25: 519-527.
18. Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, Kwong RY,. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007; 49: 855-862.
19. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R,. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1581-1587.
20. Arai AE,. Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 2000; 11: 383-398.
21. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY,. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006; 114: 32-39.
22. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Rossum AC,. Functional recovery after acute myocardial infarction: Comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008; 52: 181-189. (Pubitemid 351915778)
23. Schomig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F, Nekolla SG, Schlotterbeck K, Schuhlen H, Pache J, Seyfarth M, Martinoff S, Benzer W, Schmitt C, Dirschinger J, Schwaiger M, Kastrati A,. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: A randomized controlled trial. JAMA 2005; 293: 2865-2872.
24. Parodi G, Ndrepepa G, Kastrati A, Conti A, Mehilli J, Sciagra R, Schwaiger M, Antoniucci D, Schomig A,. Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms. Am Heart J 2006; 152: 1133-1139.
25. Ibrahim T, Bulow HP, Hackl T, Hornke M, Nekolla SG, Breuer M, Schomig A, Schwaiger M,. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 2007; 49: 208-216.
26. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr., Arai AE,. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006; 113: 1865-1870.
27. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J,. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging 2009; 2: 825-831.
28. O'Regan DP, Ahmed R, Neuwirth C, Tan Y, Durighel G, Hajnal JV, Nadra I, Corbett SJ, Cook SA,. Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention. Am J Physiol Heart Circ Physiol 2009; 297: H340-H346.
29. Carlsson M, Ubachs J, Hedström E, Heiberg E, Jovinge S, Arheden H,. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: Quantitative assessment during follow-up and validation with single-photon emission computed tomography. J Am Coll Cardiol Cardiovasc Imaging 2009; 2: 569-576.
30. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM,. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
31. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK,. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2008; 1: 415-423.
32. Schroder R,. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004; 110: e506-e510.
33. Galiuto L, Garramone B, Burzotta F, Lombardo A, Barchetta S, Rebuzzi AG, Crea F,. Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: A myocardial contrast echocardiography substudy of the REMEDIA Trial. J Am Coll Cardiol 2006; 48: 1355-1360.
34. Kramer MC, van der Wal AC, Koch KT, Ploegmakers JP, van der Schaaf RJ, Henriques JP, Baan J Jr., Rittersma SZ, Vis MM, Piek JJ, Tijssen JG, de Winter RJ,. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation 2008; 118: 1810-1816.
35. Vlaar PJ, Svilaas T, van der Horst IC, Diercks GF, Fokkema ML, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F,. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): A 1-year follow-up study. Lancet 2008; 371: 1915-1920.
36. Javaid A, Siddiqi NH, Steinberg DH, Buch AN, Slottow TL, Roy P, Sammee S, Okabe T, Suddath WO, Kent KM, Satler LF, Pichard AD, Smith K, Xue Z, Lindsay J Jr., Waksman R,. Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol 2008; 101: 452-456.
37. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, Molina-Viamonte V, Orlandi C, Blevins R, Gibbons RJ, Califf RM, Granger CB,. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711-1720.
38. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW,; AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005; 45: 1775-1780.